Global Pulmonary Drug Delivery Systems Market Growth 2021-2026
According to this latest study, the 2021 growth of Pulmonary Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Pulmonary Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2859.7 million in 2020. Over the next five years the Pulmonary Drug Delivery Systems market will register a 4.4% CAGR in terms of revenue, the global market size will reach US$ 3391.6 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
COPD
Asthma
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pulmonary Drug Delivery Systems Consumption 2016-2026
2.1.2 Pulmonary Drug Delivery Systems Consumption CAGR by Region
2.2 Pulmonary Drug Delivery Systems Segment by Type
2.2.1 Nebulizers
2.2.2 Dry Powder Inhaler (DPI)
2.2.3 Metered Dose Inhaler (MDI)
2.3 Pulmonary Drug Delivery Systems Sales by Type
2.3.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2021)
2.3.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Type (2016-2021)
2.3.3 Global Pulmonary Drug Delivery Systems Sale Price by Type (2016-2021)
2.4 Pulmonary Drug Delivery Systems Segment by Application
2.4.1 COPD
2.4.2 Asthma
2.4.3 Others
2.5 Pulmonary Drug Delivery Systems Sales by Application
2.5.1 Global Pulmonary Drug Delivery Systems Sale Market Share by Application (2016-2021)
2.5.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pulmonary Drug Delivery Systems Sale Price by Application (2016-2021)
3 Global Pulmonary Drug Delivery Systems by Company
3.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Company
3.1.1 Global Pulmonary Drug Delivery Systems Sales by Company (2019-2021)
3.1.2 Global Pulmonary Drug Delivery Systems Sales Market Share by Company (2019-2021)
3.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Company
3.2.1 Global Pulmonary Drug Delivery Systems Revenue by Company (2019-2021)
3.2.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Company (2019-2021)
3.3 Global Pulmonary Drug Delivery Systems Sale Price by Company
3.4 Global Manufacturers Pulmonary Drug Delivery Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Drug Delivery Systems Product Location Distribution
3.4.2 Players Pulmonary Drug Delivery Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pulmonary Drug Delivery Systems by Region
4.1 Global Pulmonary Drug Delivery Systems by Region
4.1.1 Global Pulmonary Drug Delivery Systems Sales by Region
4.1.2 Global Pulmonary Drug Delivery Systems Revenue by Region
4.2 Americas Pulmonary Drug Delivery Systems Sales Growth
4.3 APAC Pulmonary Drug Delivery Systems Sales Growth
4.4 Europe Pulmonary Drug Delivery Systems Sales Growth
4.5 Middle East & Africa Pulmonary Drug Delivery Systems Sales Growth
5 Americas
5.1 Americas Pulmonary Drug Delivery Systems Sales by Country
5.1.1 Americas Pulmonary Drug Delivery Systems Sales by Country (2016-2021)
5.1.2 Americas Pulmonary Drug Delivery Systems Revenue by Country (2016-2021)
5.2 Americas Pulmonary Drug Delivery Systems Sales by Type
5.3 Americas Pulmonary Drug Delivery Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Drug Delivery Systems Sales by Region
6.1.1 APAC Pulmonary Drug Delivery Systems Sales by Region (2016-2021)
6.1.2 APAC Pulmonary Drug Delivery Systems Revenue by Region (2016-2021)
6.2 APAC Pulmonary Drug Delivery Systems Sales by Type
6.3 APAC Pulmonary Drug Delivery Systems Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pulmonary Drug Delivery Systems by Country
7.1.1 Europe Pulmonary Drug Delivery Systems Sales by Country (2016-2021)
7.1.2 Europe Pulmonary Drug Delivery Systems Revenue by Country (2016-2021)
7.2 Europe Pulmonary Drug Delivery Systems Sales by Type
7.3 Europe Pulmonary Drug Delivery Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pulmonary Drug Delivery Systems by Country
8.1.1 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Country (2016-2021)
8.2 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Type
8.3 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pulmonary Drug Delivery Systems Distributors
10.3 Pulmonary Drug Delivery Systems Customer
11 Global Pulmonary Drug Delivery Systems Market Forecast
11.1 Global Pulmonary Drug Delivery Systems Forecast by Region
11.1.1 Global Pulmonary Drug Delivery Systems Forecast by Regions (2021-2026)
11.2.2 Global Pulmonary Drug Delivery Systems Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pulmonary Drug Delivery Systems Forecast by Type
11.7 Global Pulmonary Drug Delivery Systems Forecast by Application
12 Key Players Analysis
12.1 3M
12.1.1 3M Company Information
12.1.2 3M Pulmonary Drug Delivery Systems Product Offered
12.1.3 3M Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 3M Main Business Overview
12.1.5 3M Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Pulmonary Drug Delivery Systems Product Offered
12.2.3 GSK Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 AstraZeneca
12.3.1 AstraZeneca Company Information
12.3.2 AstraZeneca Pulmonary Drug Delivery Systems Product Offered
12.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 AstraZeneca Main Business Overview
12.3.5 AstraZeneca Latest Developments
12.4 Cipla
12.4.1 Cipla Company Information
12.4.2 Cipla Pulmonary Drug Delivery Systems Product Offered
12.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Cipla Main Business Overview
12.4.5 Cipla Latest Developments
12.5 Chiesi
12.5.1 Chiesi Company Information
12.5.2 Chiesi Pulmonary Drug Delivery Systems Product Offered
12.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Chiesi Main Business Overview
12.5.5 Chiesi Latest Developments
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Information
12.6.2 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Offered
12.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Boehringer Ingelheim Main Business Overview
12.6.5 Boehringer Ingelheim Latest Developments
12.7 Aptar
12.7.1 Aptar Company Information
12.7.2 Aptar Pulmonary Drug Delivery Systems Product Offered
12.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Aptar Main Business Overview
12.7.5 Aptar Latest Developments
12.8 Novartis
12.8.1 Novartis Company Information
12.8.2 Novartis Pulmonary Drug Delivery Systems Product Offered
12.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Novartis Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Philips Respironics
12.9.1 Philips Respironics Company Information
12.9.2 Philips Respironics Pulmonary Drug Delivery Systems Product Offered
12.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Philips Respironics Main Business Overview
12.9.5 Philips Respironics Latest Developments
12.10 Omron Healthcare
12.10.1 Omron Healthcare Company Information
12.10.2 Omron Healthcare Pulmonary Drug Delivery Systems Product Offered
12.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Omron Healthcare Main Business Overview
12.10.5 Omron Healthcare Latest Developments
12.11 PARI
12.11.1 PARI Company Information
12.11.2 PARI Pulmonary Drug Delivery Systems Product Offered
12.11.3 PARI Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 PARI Main Business Overview
12.11.5 PARI Latest Developments
12.12 Skyepharma
12.12.1 Skyepharma Company Information
12.12.2 Skyepharma Pulmonary Drug Delivery Systems Product Offered
12.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Skyepharma Main Business Overview
12.12.5 Skyepharma Latest Developments
12.13 CareFusion
12.13.1 CareFusion Company Information
12.13.2 CareFusion Pulmonary Drug Delivery Systems Product Offered
12.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 CareFusion Main Business Overview
12.13.5 CareFusion Latest Developments
12.14 Shanghai Huarui
12.14.1 Shanghai Huarui Company Information
12.14.2 Shanghai Huarui Pulmonary Drug Delivery Systems Product Offered
12.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Shanghai Huarui Main Business Overview
12.14.5 Shanghai Huarui Latest Developments
12.15 Taian Character
12.15.1 Taian Character Company Information
12.15.2 Taian Character Pulmonary Drug Delivery Systems Product Offered
12.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Taian Character Main Business Overview
12.15.5 Taian Character Latest Developments
12.16 Chia Tai Tianqing
12.16.1 Chia Tai Tianqing Company Information
12.16.2 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Offered
12.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Chia Tai Tianqing Main Business Overview
12.16.5 Chia Tai Tianqing Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Pulmonary Drug Delivery Systems Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Nebulizers
Table 3. Major Players of Dry Powder Inhaler (DPI)
Table 4. Major Players of Metered Dose Inhaler (MDI)
Table 5. Global Pulmonary Drug Delivery Systems Sales by Type (2016-2021) & (M Units)
Table 6. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2021)
Table 7. Global Pulmonary Drug Delivery Systems Revenue by Type (2016-2021) & ($ million)
Table 8. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2016-2021)
Table 9. Global Pulmonary Drug Delivery Systems Sale Price by Type (2016-2021)
Table 10. Global Pulmonary Drug Delivery Systems Sales by Application (2016-2021) & (M Units)
Table 11. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2021)
Table 12. Global Pulmonary Drug Delivery Systems Value by Application (2016-2021)
Table 13. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2016-2021)
Table 14. Global Pulmonary Drug Delivery Systems Sale Price by Application (2016-2021)
Table 15. Global Pulmonary Drug Delivery Systems Sales by Company (2019-2021) & (M Units)
Table 16. Global Pulmonary Drug Delivery Systems Sales Market Share by Company (2019-2021)
Table 17. Global Pulmonary Drug Delivery Systems Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Pulmonary Drug Delivery Systems Revenue Market Share by Company (2019-2021)
Table 19. Global Pulmonary Drug Delivery Systems Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Pulmonary Drug Delivery Systems Producing Area Distribution and Sales Area
Table 21. Players Pulmonary Drug Delivery Systems Products Offered
Table 22. Pulmonary Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pulmonary Drug Delivery Systems Sales by Region (2016-2021) (M Units)
Table 26. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2016-2021)
Table 27. Global Pulmonary Drug Delivery Systems Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2016-2021)
Table 29. Americas Pulmonary Drug Delivery Systems Sales by Country (2016-2021) & (M Units)
Table 30. Americas Pulmonary Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 31. Americas Pulmonary Drug Delivery Systems Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Pulmonary Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 33. Americas Pulmonary Drug Delivery Systems Sales by Type (2016-2021) & (M Units)
Table 34. Americas Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2021)
Table 35. Americas Pulmonary Drug Delivery Systems Sales by Application (2016-2021) & (M Units)
Table 36. Americas Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2021)
Table 37. APAC Pulmonary Drug Delivery Systems Sales by Region (2016-2021) & (M Units)
Table 38. APAC Pulmonary Drug Delivery Systems Sales Market Share by Region (2016-2021)
Table 39. APAC Pulmonary Drug Delivery Systems Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Pulmonary Drug Delivery Systems Revenue Market Share by Region (2016-2021)
Table 41. APAC Pulmonary Drug Delivery Systems Sales by Type (2016-2021) & (M Units)
Table 42. APAC Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2021)
Table 43. APAC Pulmonary Drug Delivery Systems Sales by Application (2016-2021) & (M Units)
Table 44. APAC Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2021)
Table 45. Europe Pulmonary Drug Delivery Systems Sales by Country (2016-2021) & (M Units)
Table 46. Europe Pulmonary Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 47. Europe Pulmonary Drug Delivery Systems Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 49. Europe Pulmonary Drug Delivery Systems Sales by Type (2016-2021) & (M Units)
Table 50. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2021)
Table 51. Europe Pulmonary Drug Delivery Systems Sales by Application (2016-2021) & (M Units)
Table 52. Europe Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Country (2016-2021) & (M Units)
Table 54. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Pulmonary Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Type (2016-2021) & (M Units)
Table 58. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Application (2016-2021) & (M Units)
Table 60. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Pulmonary Drug Delivery Systems
Table 62. Key Application and Potential Industries of Pulmonary Drug Delivery Systems
Table 63. Key Challenges of Pulmonary Drug Delivery Systems
Table 64. Key Trends of Pulmonary Drug Delivery Systems
Table 65. Pulmonary Drug Delivery Systems Distributors List
Table 66. Pulmonary Drug Delivery Systems Customer List
Table 67. Global Pulmonary Drug Delivery Systems Sales Forecast by Region (2021-2026) & (M Units)
Table 68. Global Pulmonary Drug Delivery Systems Consumption Market Forecast by Region
Table 69. Global Pulmonary Drug Delivery Systems Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Pulmonary Drug Delivery Systems Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Pulmonary Drug Delivery Systems Sales Forecast by Country (2021-2026) & (M Units)
Table 72. Americas Pulmonary Drug Delivery Systems Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Pulmonary Drug Delivery Systems Sales Forecast by Region (2021-2026) & (M Units)
Table 74. APAC Pulmonary Drug Delivery Systems Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Pulmonary Drug Delivery Systems Sales Forecast by Country (2021-2026) & (M Units)
Table 76. Europe Pulmonary Drug Delivery Systems Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Pulmonary Drug Delivery Systems Sales Forecast by Country (2021-2026) & (M Units)
Table 78. Middle East & Africa Pulmonary Drug Delivery Systems Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Pulmonary Drug Delivery Systems Sales Forecast by Type (2021-2026) & (M Units)
Table 80. Global Pulmonary Drug Delivery Systems Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Pulmonary Drug Delivery Systems Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Pulmonary Drug Delivery Systems Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Pulmonary Drug Delivery Systems Sales Forecast by Application (2021-2026) & (M Units)
Table 84. Global Pulmonary Drug Delivery Systems Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Pulmonary Drug Delivery Systems Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Pulmonary Drug Delivery Systems Revenue Market Share Forecast by Application (2021-2026)
Table 87. 3M Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 88. 3M Pulmonary Drug Delivery Systems Product Offered
Table 89. 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. 3M Main Business
Table 91. 3M Latest Developments
Table 92. GSK Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Pulmonary Drug Delivery Systems Product Offered
Table 94. GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. AstraZeneca Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Pulmonary Drug Delivery Systems Product Offered
Table 99. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. Cipla Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 103. Cipla Pulmonary Drug Delivery Systems Product Offered
Table 104. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Cipla Main Business
Table 106. Cipla Latest Developments
Table 107. Chiesi Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 108. Chiesi Pulmonary Drug Delivery Systems Product Offered
Table 109. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Chiesi Main Business
Table 111. Chiesi Latest Developments
Table 112. Boehringer Ingelheim Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 113. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Offered
Table 114. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Boehringer Ingelheim Main Business
Table 116. Boehringer Ingelheim Latest Developments
Table 117. Aptar Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 118. Aptar Pulmonary Drug Delivery Systems Product Offered
Table 119. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Aptar Main Business
Table 121. Aptar Latest Developments
Table 122. Novartis Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 123. Novartis Pulmonary Drug Delivery Systems Product Offered
Table 124. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Novartis Main Business
Table 126. Novartis Latest Developments
Table 127. Philips Respironics Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 128. Philips Respironics Pulmonary Drug Delivery Systems Product Offered
Table 129. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Philips Respironics Main Business
Table 131. Philips Respironics Latest Developments
Table 132. Omron Healthcare Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 133. Omron Healthcare Pulmonary Drug Delivery Systems Product Offered
Table 134. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Omron Healthcare Main Business
Table 136. Omron Healthcare Latest Developments
Table 137. PARI Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 138. PARI Pulmonary Drug Delivery Systems Product Offered
Table 139. PARI Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. PARI Main Business
Table 141. PARI Latest Developments
Table 142. Skyepharma Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 143. Skyepharma Pulmonary Drug Delivery Systems Product Offered
Table 144. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Skyepharma Main Business
Table 146. Skyepharma Latest Developments
Table 147. CareFusion Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 148. CareFusion Pulmonary Drug Delivery Systems Product Offered
Table 149. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. CareFusion Main Business
Table 151. CareFusion Latest Developments
Table 152. Shanghai Huarui Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Huarui Pulmonary Drug Delivery Systems Product Offered
Table 154. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 155. Shanghai Huarui Main Business
Table 156. Shanghai Huarui Latest Developments
Table 157. Taian Character Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 158. Taian Character Pulmonary Drug Delivery Systems Product Offered
Table 159. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 160. Taian Character Main Business
Table 161. Taian Character Latest Developments
Table 162. Chia Tai Tianqing Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 163. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Offered
Table 164. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 165. Chia Tai Tianqing Main Business
Table 166. Chia Tai Tianqing Latest Developments
List of Figures
Figure 1. Picture of Pulmonary Drug Delivery Systems
Figure 2. Pulmonary Drug Delivery Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Drug Delivery Systems Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Pulmonary Drug Delivery Systems Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Pulmonary Drug Delivery Systems Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Nebulizers
Figure 10. Product Picture of Dry Powder Inhaler (DPI)
Figure 11. Product Picture of Metered Dose Inhaler (MDI)
Figure 12. Global Pulmonary Drug Delivery Systems Sales Market Share by Type in 2020
Figure 13. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2016-2021)
Figure 14. Pulmonary Drug Delivery Systems Consumed in COPD
Figure 15. Global Pulmonary Drug Delivery Systems Market: COPD (2016-2021) & (M Units)
Figure 16. Pulmonary Drug Delivery Systems Consumed in Asthma
Figure 17. Global Pulmonary Drug Delivery Systems Market: Asthma (2016-2021) & (M Units)
Figure 18. Pulmonary Drug Delivery Systems Consumed in Others
Figure 19. Global Pulmonary Drug Delivery Systems Market: Others (2016-2021) & (M Units)
Figure 20. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2021)
Figure 21. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application in 2020
Figure 22. Pulmonary Drug Delivery Systems Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Pulmonary Drug Delivery Systems Revenue Market Share by Company in 2020
Figure 24. Global Pulmonary Drug Delivery Systems Sales Market Share by Regions (2016-2021)
Figure 25. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region in 2020
Figure 26. Americas Pulmonary Drug Delivery Systems Sales 2016-2021 (M Units)
Figure 27. Americas Pulmonary Drug Delivery Systems Revenue 2016-2021 ($ Millions)
Figure 28. APAC Pulmonary Drug Delivery Systems Sales 2016-2021 (M Units)
Figure 29. APAC Pulmonary Drug Delivery Systems Revenue 2016-2021 ($ Millions)
Figure 30. Europe Pulmonary Drug Delivery Systems Sales 2016-2021 (M Units)
Figure 31. Europe Pulmonary Drug Delivery Systems Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Pulmonary Drug Delivery Systems Sales 2016-2021 (M Units)
Figure 33. Middle East & Africa Pulmonary Drug Delivery Systems Revenue 2016-2021 ($ Millions)
Figure 34. Americas Pulmonary Drug Delivery Systems Sales Market Share by Country in 2020
Figure 35. Americas Pulmonary Drug Delivery Systems Revenue Market Share by Country in 2020
Figure 36. Americas Pulmonary Drug Delivery Systems Sales Market Share by Type in 2020
Figure 37. Americas Pulmonary Drug Delivery Systems Sales Market Share by Application in 2020
Figure 38. United States Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Pulmonary Drug Delivery Systems Sales Market Share by Region in 2020
Figure 43. APAC Pulmonary Drug Delivery Systems Revenue Market Share by Regions in 2020
Figure 44. APAC Pulmonary Drug Delivery Systems Sales Market Share by Type in 2020
Figure 45. APAC Pulmonary Drug Delivery Systems Sales Market Share by Application in 2020
Figure 46. China Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Pulmonary Drug Delivery Systems Sales Market Share by Country in 2020
Figure 53. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Country in 2020
Figure 54. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type in 2020
Figure 55. Europe Pulmonary Drug Delivery Systems Sales Market Share by Application in 2020
Figure 56. Germany Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Pulmonary Drug Delivery Systems Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Application in 2020
Figure 65. Egypt Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Pulmonary Drug Delivery Systems Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
